Health

  • January 30, 2026

    Mangione Won't Face Death Penalty, Judge Rules

    A Manhattan federal judge on Friday took the death penalty off the table for Luigi Mangione, dismissing a capital count and setting up an October trial that could see him go to prison for life without the possibility of release.

  • January 29, 2026

    Fitness App Must Face Trimmed Suit Over Tracking Cookies

    A California federal judge cut several wiretap and fraud claims from a proposed class action accusing MyFitnessPal of allowing third parties to track the browsing activities of website visitors who rejected the use of tracking cookies while allowing the plaintiffs to proceed with invasion of privacy and two other allegations.

  • January 29, 2026

    DOL Proposes Pharmacy Benefit Manager Fee Disclosure Rule

    The U.S. Department of Labor's employee benefits subagency Thursday proposed a rule to require new fee disclosures from pharmacy benefit managers, which act as intermediaries between drugmakers, pharmacies and insurers, to help managers of employee health plans ensure PBM services are reasonably priced.

  • January 29, 2026

    Pa. Nursing Home Disputes Patient Death Suits' Coverage Cap

    A Pennsylvania nursing home told a federal court that an insurer should pay up to $3 million in coverage for lawsuits by six patients' estates alleging a staff member murdered them, arguing the insurer misconstrued a state medical negligence statute in order to limit coverage.

  • January 29, 2026

    Conn. Drug Price Cap Survives Distributor Challenge, For Now

    The Second Circuit has declined a bid to immediately block the state of Connecticut from enforcing a cap on generic and off-patent drug prices while the Healthcare Distribution Alliance, a collection of wholesale distributors, challenges the new law.

  • January 29, 2026

    ITC To Review Medical Imaging Imports For Infringement

    The U.S. International Trade Commission said it is looking into medical imaging device imports for alleged patent infringement in response to a complaint from a Canadian-American firm.

  • January 29, 2026

    Teva Tries To Spike Paragard Trial Claims, Punitive Damages

    About a week into its first trial over the alleged dangers of the Paragard contraceptive, Teva Pharmaceuticals asked a Georgia federal judge Wednesday to cut the case short and hand it an early win, or at least let it out of a bid for punitive damages.

  • January 29, 2026

    United Healthcare Beats Class Cert. Bid Over Breast Surgery

    A New Jersey federal judge on Wednesday declined to certify a proposed class of United Healthcare Insurance plan participants who were denied coverage for post-mastectomy breast reconstruction surgery, finding that she can't determine which standard of review applies to each plan's varying language without conducting individualized, fact-specific inquiries. 

  • January 29, 2026

    Inspire Medical Leaders Face Suit Over Apnea Device Rollout

    Brass of Inspire Medical Systems Inc. face shareholder derivative claims they breached their fiduciary duties by concealing issues affecting the launch of the company's latest sleep apnea device, damaging investors after its trading prices fell 32% when the issues were disclosed.

  • January 29, 2026

    Sandoz, Teva Beat Malicious Prosecution Claims, For Now

    Sandoz and Teva have won a reprieve from a former pharmaceutical marketing executive claiming the drugmakers and their officers offered him up to federal prosecutors with fabricated assertions of price-fixing, with a New York federal judge concluding the suit "does not come close" to the standard for malicious prosecution.

  • January 29, 2026

    Nurse Fired In Pandemic-Era RIF Can't Reinstate Age Bias Suit

    The Sixth Circuit backed the dismissal of an age bias suit from a nurse who claimed a medical center used a COVID-19-related reduction in force as an excuse to fire her, ruling a supervisor calling one of her colleagues a "young star" wasn't linked to her termination.

  • January 29, 2026

    Healthcare Group Of The Year: Bass Berry

    Bass Berry & Sims PLC's recent work advising Sycamore Partners on its $23.7 billion acquisition of Walgreens Boots Alliance, taking the pharmacy retailer off the public market, has earned the firm a spot among the 2025 Law360 Healthcare Groups of the Year.

  • January 28, 2026

    Biogen Can't Escape Amended Antitrust Suit Over MS Drug

    Biogen Inc. must face health plans' claims that it bribed pharmacy benefit managers to stifle generics competition for its multiple sclerosis drug Tecfidera, after an Illinois federal judge found Wednesday that the plans' latest amended complaint in their consolidated antitrust litigation corrects her prior concerns with the pleadings.

  • January 28, 2026

    Ambulance Billing Co. Settles Data Breach Claims

    An ambulance billing service will pay a total of $515,000 to the states of Massachusetts and Connecticut and take measures to improve its data security to settle allegations stemming from a 2022 breach, the Massachusetts Attorney General's Office announced Wednesday.

  • January 28, 2026

    NM Bill Could Shield Medical Cannabis Users From Job Bias

    Democratic lawmakers in New Mexico's Legislature are looking to redefine employment rules for medical cannabis patients to prohibit bosses from taking adverse actions for lawful off-duty use but allow them to restrict use for certain roles or carry out discipline for impairment at work.

  • January 28, 2026

    Fla. Court Undoes Class Cert. Of Medicare Cos. In USAA Suit

    A Florida state appeals court on Wednesday reversed class certification for a group of Medicare-contracted businesses suing USAA Casualty Insurance Co. over allegations the insurer sidestepped its obligation to pay automobile injury claims and passed them on to so-called secondary payers. 

  • January 28, 2026

    NY Firm And Medical Providers Defrauded Insurers, Suit Says

    An insurer accused a law firm and a collection of medical providers and professionals of engaging in a scheme to defraud insurers through sham lawsuits and inflated medical bills, telling a New York federal court that the defendants have enriched themselves "at the expense of justice, equity and human dignity."

  • January 28, 2026

    BlackRock, Eclipse Lead Cellares' $257M Funding Round

    Integrated development and manufacturing organization company Cellares, which focuses on the large-scale manufacturing of cell therapies, on Wednesday announced that it closed a $257 million funding round, bringing the South San Francisco, California-based company's total capital raised to $612 million.

  • January 28, 2026

    ArentFox Schiff Launches Longevity Industry Group

    ArentFox Schiff LLP on Wednesday announced the launch of a group geared toward advising companies focused on advancing wellness, preventive health care and the longevity of life.

  • January 28, 2026

    Employee Exodus Prompts CEO Defamation Lawsuit

    Employees moving from one Turkish company to another has led to a $5.5 million defamation lawsuit between the CEOs of their American affiliates, according to a complaint filed in a federal court in Pennsylvania.

  • January 28, 2026

    Healthcare Group Of The Year: McDermott

    McDermott Will & Schulte attorneys advised Northwell Health hospital and health system through its integration with Nuvance Health and represented Lee Equity Partners and Solaris Health in the $1.9 billion sale of Solaris to Cardinal Health Platform, The Specialty Alliance, earning it a spot among the 2025 Law360 Healthcare Practice Groups of the Year. 

  • January 28, 2026

    False Claims Expert Moves Philly Practice To Holland & Knight

    Increased activity in litigation involving health care law and the False Claims Act has prompted a Philadelphia attorney to move her practice to Holland & Knight LLP after nearly 20 years at Morgan Lewis & Bockius LLP.

  • January 28, 2026

    Generics Makers Want Hospital Drug Data In Price-Fixing MDL

    A group of 150 hospitals suing generic-drug makers for alleged price fixing in multidistrict litigation should hand over data on their drug purchases, the drugmakers have told a Pennsylvania federal court, arguing they don't sell directly to the hospitals and therefore have no records themselves. 

  • January 28, 2026

    GAO Dismisses Ohio Co.'s Challenge To VA Bid Rejection

    The U.S. Government Accountability Office said an Ohio company's disagreement with a U.S. Department of Veterans Affairs decision to reject its bid for a medical center renovation over performance concerns belonged with the Small Business Administration.

  • January 28, 2026

    Call Center Workers Ink Wage Deal With Disability Nonprofit

    A disability services nonprofit has agreed to pay $76,500 to settle a suit accusing it of failing to pay call center employees for work before shifts and during unpaid meal breaks and of miscalculating their overtime, the workers told a Virginia federal court.

Expert Analysis

  • Series

    Muay Thai Makes Me A Better Lawyer

    Author Photo

    Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.

  • The Next Pressure Point In Digital Health: Informed Consent

    Author Photo

    Two new federal digital health initiatives will usher in a new era where virtual care, software-enabled devices and home-based monitoring are integrated into care and reimbursement models, with the impact of shifting rules and opportunities felt most immediately in the context of informed consent, says Kimberly Chew at Husch Blackwell.

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • 4 Trends Shaping Drug And Medical Device Law For 2026

    Author Photo

    2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intelligence, say attorneys at Faegre Drinker.

  • Key Trends In Healthcare Antitrust In 2025

    Author Photo

    The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.

  • The 5 Most Important Bid Protest Decisions Of 2025

    Author Photo

    In a shifting bid protest landscape, five decisions in 2025 from the Federal Circuit, the U.S. Court of Federal Claims and the U.S. Government Accountability Office that addressed bedrock questions about jurisdictional reach and the breadth of agency discretion are likely to have a lasting impact, say attorneys at Bradley Arant.

  • Food Industry Braces For MAHA And Other Challenges In 2026

    Author Photo

    After the Make America Healthy Again movement kept the U.S. Food and Drug Administration under pressure in 2025, actions in the food safety space are likely to continue this year, including updated Supplemental Nutrition Assistance Program dietary guidelines and processed food definitions, say attorneys at Wiley.

  • Preparing For Congressional Investigations In A Midterm Year

    Author Photo

    2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.

  • A Meaningful Shift In FDA's Biosimilarity Analysis

    Author Photo

    The U.S. Food and Drug Administration's potential pivot away from routinely requiring comparative efficacy studies for interchangeable biosimilar applications would not lower regulatory standards, but instead allow applicants to allocate resources toward establishing more probative evidence, says Theodore Thompson at Stinson.

  • Employment Immigration Trends And Challenges For 2026

    Author Photo

    U.S. companies competing for global talent should brace for a turbulent 2026, with greater compliance burdens, higher costs and the probability of workforce disruptions at every stage of the immigration process, from visa petitions to work authorization renewals, say attorneys at Duane Morris.

  • Top 5 Antitrust Issues For In-House Counsel To Watch In 2026

    Author Photo

    With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • Health, Legal Employers Face Unique Online Speech Hurdles

    Author Photo

    Employers in the legal and healthcare industries must consider distinctive ethical obligations and professional requirements when disciplining employees for social media posts, while anticipating an area of the law in flux as courts seek to balance speech rights and the workplace function, say attorneys at FordHarrison.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.